Stock Price, News, Quote and Profile of ABBOTT LABORATORIES(NYSE:ABT) stock

ABBOTT LABORATORIES

NYSE:ABT (12/26/2024, 11:29:07 AM)

115.52

+0.76 (+0.66%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorHealth Care

GICS IndustryHealth Care Equipment & Supplies

GICS SubIndustryHealth Care Equipment

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Chartmill High Growth Momentum

EPS Q2Q%6.14%

Sales Q2Q%4.85%

CRS57.15

6 Month10.44%

Overview

Earnings (Last)10-16 2024-10-16/bmo

Earnings (Next)01-22 2025-01-22/amc

Ins Owners0.47%

Inst Owners77.54%

Market Cap200.36B

Shares1.73B

PE25.56

Fwd PE22.16

Dividend Yield2.1%

Analysts80.63

Short Float %0.79%

Short Ratio2.69

IPO03-01 1937-03-01

Stock Screener Links

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

GICS Sector Stock Screener

Find competitors from the same sector on the USA

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The firm is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The firm operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.